Physiologically based pharmacokinetic modeling as a tool for drug development

[1]  Ryosei Kawai,et al.  Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125 , 1994, Journal of Pharmacokinetics and Biopharmaceutics.

[2]  P. Wedeking,et al.  A multi-organ, axially distributed model of capillary permeability for a magnetic resonance imaging contrast agent. , 1993, Journal of pharmaceutical sciences.

[3]  M E Andersen,et al.  Physiological pharmacokinetics and cancer risk assessment. , 1993, Cancer letters.

[4]  Ajaz S. Hussain,et al.  Feasibility of Developing a Neural Network for Prediction of Human Pharmacokinetic Parameters from Animal Data , 1993, Pharmaceutical Research.

[5]  Peter Veng-Pedersen,et al.  Neural networks in pharmacodynamic modeling. Is current modeling practice of complex kinetic systems at a dead end? , 1992, Journal of Pharmacokinetics and Biopharmaceutics.

[6]  S. Cammisuli,et al.  The new cyclosporine derivative, SDZ IMM 125: in vitro and in vivo pharmacologic effects. , 1992, Transplantation proceedings.

[7]  J. Brockmöller,et al.  Evaluation of Hepatic Function Using the Pharmacokinetics of a Therapeutically Administered Drug , 1992, Clinical pharmacokinetics.

[8]  H. Leung,et al.  Use of physiologically based pharmacokinetic models to establish biological exposure indexes. , 1992, American Industrial Hygiene Association journal.

[9]  R. E. Boyd,et al.  Physiological modeling of disposition of potential tumor-imaging radiopharmaceuticals in tumor-bearing mice. , 1992, Journal of pharmaceutical sciences.

[10]  R. Dedrick,et al.  Physiological pharmacokinetic parameters for cis-dichlorodiammineplatinum(II) (DDP) in the mouse , 1992, Journal of Pharmacokinetics and Biopharmaceutics.

[11]  M E Phelps,et al.  Noninvasive quantification of hepatic arterial blood flow with nitrogen-13-ammonia and dynamic positron emission tomography. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  J. Mordenti,et al.  Extrapolation of Toxicological and Pharmacological Data from Animals to Humans , 1991 .

[13]  Mark A. Johnson,et al.  A graph-theoretic approach to modeling metabolic pathways , 1991, J. Comput. Aided Mol. Des..

[14]  T. Ludden,et al.  Application of population analysis to physiological pharmacokinetics , 1991, Journal of Pharmacokinetics and Biopharmaceutics.

[15]  A. Khalique,et al.  Physiological pharmacokinetic and pharmacodynamic model of physostigmine in the rat. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[16]  H W Leung,et al.  Development and utilization of physiologically based pharmacokinetic models for toxicological applications. , 1991, Journal of toxicology and environmental health.

[17]  Robert D. Johnson,et al.  Application of Neural Computing in Pharmaceutical Product Development , 1991, Pharmaceutical Research.

[18]  D. M. Hetrick,et al.  Sensitivity analysis for physiologically based pharmacokinetic models , 1991, Journal of Pharmacokinetics and Biopharmaceutics.

[19]  R. Ings,et al.  Interspecies scaling and comparisons in drug development and toxicokinetics. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.

[20]  Melvin E. Andersen,et al.  Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropyfluorophosphate , 1990 .

[21]  L. Balant,et al.  Pharmacokinetic Criteria for Drug Research and Development , 1990 .

[22]  J M Collins,et al.  Extrapolation of animal toxicity to humans: interspecies comparisons in drug development. , 1990, Regulatory toxicology and pharmacology : RTP.

[23]  D. Strandness,et al.  Estimation of Hepatic Blood Flow in Branches of Hepatic Vessels Utilizing a Noninvasive, Duplex Doppler Method , 1990, Journal of clinical pharmacology.

[24]  Y. Sugiyama,et al.  Receptor-mediated disposition of polypeptides: Kinetic analysis of the transport of epidermal growth factor as a model peptide using in vitro isolated perfused organs and in vivo system☆ , 1990 .

[25]  F Y Bois,et al.  Precision and sensitivity of pharmacokinetic models for cancer risk assessment: tetrachloroethylene in mice, rats, and humans. , 1990, Toxicology and applied pharmacology.

[26]  P O Droz,et al.  Variability in biological monitoring of solvent exposure. I. Development of a population physiological model. , 1989, British journal of industrial medicine.

[27]  D. Perrier,et al.  Physiological pharmacokinetie model of adriamycin delivered via magnetic albumin microspheres in the rat , 1989, Journal of Pharmacokinetics and Biopharmaceutics.

[28]  A. Boddy,et al.  Efficiency of Drug Targeting: Steady-State Considerations Using a Three-Compartment Model , 1989, Pharmaceutical Research.

[29]  W A Colburn,et al.  Physiologic Pharmacokinetic Modeling , 1988, Journal of clinical pharmacology.

[30]  F. Weber,et al.  Noninvasive, quantitative determination of muscle blood flow in man by a combination of venous-occlusion plethysmography and computed tomography , 1988, Basic Research in Cardiology.

[31]  H. Boxenbaum,et al.  Quantitative Structure–Activity Study on Human Pharmacokinetic Parameters of Benzodiazepines Using the Graph Theoretical Approach , 1988, Pharmaceutical Research.

[32]  R W D'Souza,et al.  Physiological Pharmacokinetic Models: Some Aspects of Theory, Practice and Potential , 1988, Toxicology and industrial health.

[33]  R. Lutz,et al.  Implications of pharmacokinetic modeling in risk assessment analysis. , 1987, Environmental health perspectives.

[34]  F. Jelovsek,et al.  Pharmacokinetics and expert systems as aids for risk assessment in reproductive toxicology. , 1987, Environmental health perspectives.

[35]  D B Menzel,et al.  ES Series: Cancer Risk Assessment. 2. Physiological pharmacokinetic modeling. , 1987, Environmental science & technology.

[36]  Y. Sawada,et al.  Physiologically based pharmacokinetics of radioiodinated human beta-endorphin in rats. An application of the capillary membrane-limited model. , 1987, Drug metabolism and disposition: the biological fate of chemicals.

[37]  M. Relling,et al.  Simultaneous administration of multiple model substrates to assess hepatic drug clearance , 1987, Clinical pharmacology and therapeutics.

[38]  N. Schork,et al.  Research utility of noninvasive methods for measurement of cardiac output , 1987, Clinical pharmacology and therapeutics.

[39]  R. Dedrick,et al.  Erratum to: Physiological pharmacokinetic modeling ofcis-dichlorodiammineplatinum (II) (DDP) in several species , 1986, Journal of Pharmacokinetics and Biopharmaceutics.

[40]  C. Anthony Hunt,et al.  Engineering Targeted In Vivo Drug Delivery. I. The Physiological and Physicochemical Principles Governing Opportunities and Limitations , 1986, Pharmaceutical Research.

[41]  J. Mordenti,et al.  Man versus beast: pharmacokinetic scaling in mammals. , 1986, Journal of pharmaceutical sciences.

[42]  Ritschel Wa,et al.  Physiological pharmacokinetic models: principles, applications, limitations and outlook. , 1986 .

[43]  J N Weinstein,et al.  Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice. , 1986, Cancer research.

[44]  R K Jain,et al.  Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.

[45]  R. J. Lutz,et al.  A review of the applications of physiologically based pharmacokinetic modeling , 1979, Journal of Pharmacokinetics and Biopharmaceutics.

[46]  E. E. Mitchell,et al.  Advanced Continuous Simulation Language (ACSL) , 1976 .

[47]  K. Bischoff,et al.  Methotrexate pharmacokinetics. , 1971, Journal of pharmaceutical sciences.

[48]  K. Bischoff,et al.  Preliminary model for methotrexate pharmacokinetics. , 1970, Journal of pharmaceutical sciences.

[49]  R. Bellman,et al.  Some mathematical aspects of chemotherapy-I: one-organ models. , 1960 .

[50]  H. Haggard,et al.  THE ABSORPTION, DISTRIBUTION, AND ELIMINATION OF ETHYL ETHER II. ANALYSIS OF THE MECHANISM OF ABSORPTION AND ELIMINATION OF SUCH A GAS OR VAPOR AS ETHYL ETHER , 1924 .

[51]  R. Terg,et al.  Noninvasive measurement of portal venous blood flow in patients with cirrhosis , 2005, Digestive Diseases and Sciences.

[52]  W. Wolf,et al.  A kinetic model for99mTc-DMSA in the rat , 2005, European Journal of Nuclear Medicine.

[53]  J. Blancato.  Physiologically-based pharmacokinetic models in risk and exposure assessment. , 1991, Annali dell'Istituto superiore di sanita.

[54]  M E Andersen,et al.  Biologically based pharmacodynamic models: tools for toxicological research and risk assessment. , 1991, Annual review of pharmacology and toxicology.

[55]  C. Travis,et al.  Physiologically Based Pharmacokinetic Models: Applications in Carcinogenic Risk Assessment , 1991 .

[56]  M. Andersen,et al.  PHYSIOLOGICAL MODELING AND CANCER RISK ASSESSMENT , 1991 .

[57]  Blancato Jn.  Physiologically-based pharmacokinetic models in risk and exposure assessment. , 1991 .

[58]  A. Atkinson,et al.  Physiological basis of multicompartmental models of drug distribution. , 1991, Trends in pharmacological sciences.

[59]  H J Clewell,et al.  Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate. , 1990, Toxicology and applied pharmacology.

[60]  L. Notarianni.  Plasma Protein Binding of Drugs in Pregnancy and in Neonates , 1990, Clinical pharmacokinetics.

[61]  H. Boxenbaum,et al.  Interspecies pharmacokinetic scaling, biological design and neoteny , 1990 .

[62]  L. P. Balant,et al.  Review Physiological pharmacokinetic modelling , 1990 .

[63]  R. Verbeeck,et al.  Plasma Protein Binding of Drugs in the Elderly , 1987, Clinical pharmacokinetics.

[64]  M Rowland,et al.  Physiologic pharmacokinetic models and interanimal species scaling. , 1985, Pharmacology & therapeutics.

[65]  M. Rowland.  Physiologic pharmacokinetic models: relevance, experience, and future trends. , 1984, Drug metabolism reviews.

[66]  W W MAPLESON,et al.  An electric analogue for uptake and exchange of inert gases and other agents. , 1963, Journal of applied physiology.

[67]  Torsten Teorell,et al.  Kinetics of distribution of substances administered to the body, II : The intravascular modes of administration , 1937 .